Skip to content
Terminus Peptides
Sign inContact
  • Research use only — not for human or veterinary use
  • 67 compound profiles, every source cited
  • 29 research materials listed
  • Prices published, not hidden behind an enquiry
  • Vials and pre-filled pens
  • Dispatched and supported from the UK
  • Every profile states its UK regulatory status
  • 5% off paying by cryptocurrency
  • Free UK delivery over £75

Research library

Research updates

What has changed in the library, and when — profiles reviewed, citations added, evidence levels moved, regulatory positions updated. Entries appear when something actually changes, not on a schedule.

  1. 27 August 2026

    Five compound comparisons published

    Side-by-side comparison pages are now part of the library, for the pairs most often discussed together or confused: BPC-157 vs TB-500, the three incretin-pathway peptides (semaglutide, tirzepatide, retatrutide), Melanotan I vs Melanotan II, Selank vs Semax, and CJC-1295 vs ipamorelin. Every fact on a comparison page restates the full profiles, which carry the citations; the comparisons add arrangement, never new claims.

    BPC-157TB-500SemaglutideTirzepatideRetatrutideMelanotan IMelanotan IISelankSemaxCJC-1295 with DACIpamorelin

  2. 23 August 2026

    Storage conditions stated across the catalogue

    Every listed material now states its storage conditions as supplied, derived from the strength unit of each product. The laboratory standards section was updated in the same change so that the storage statements and the standards page could not disagree.